Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Entrada Therapeutics, Inc. | 4,425,784 | 4,425,784 | 0 | 63,067 | 70,724 | 48.68% | +7,657 |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | 7,401 | 7,715 | 5.31% | +314 |
| Adaptimmune Therapeutics plc | 5,555,461 | 5,555,461 | 0 | 5,417 | 5,278 | 3.63% | -139 |
| Werewolf Therapeutics, Inc. | 4,284,172 | 4,284,172 | 0 | 10,453 | 9,082 | 6.25% | -1,371 |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | 40,644 | 27,963 | 19.25% | -12,681 |
| Dyne Therapeutics, Inc.(DYN) | 1,561,496 | 682,376 | -879,120 | 55,105 | 24,511 | 16.87% | -30,594 |